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Abstract
Development and application of advanced mechanical models of soft tissues and their growth represent one of the main 
directions in modern mechanics of solids. Such models are increasingly used to deal with complex biomedical problems. 
Prediction of in-stent restenosis for patients treated with coronary stents remains a highly challenging task. Using a finite 
element method, this paper presents a mechanistic approach to evaluate the development of in-stent restenosis in an artery 
following stent implantation. Hyperelastic models with damage, verified with experimental results, are used to describe the 
level of tissue damage in arterial layers and plaque caused by such intervention. A tissue-growth model, associated with 
vessel damage, is adopted to describe the growth behaviour of a media layer after stent implantation. Narrowing of lumen 
diameter with time is used to quantify the development of in-stent restenosis in the vessel after stenting. It is demonstrated that 
stent designs and materials strongly affect the stenting-induced damage in the media layer and the subsequent development 
of in-stent restenosis. The larger the artery expansion achieved during balloon inflation, the higher the damage introduced 
to the media layer, leading to an increased level of in-stent restenosis. In addition, the development of in-stent restenosis is 
directly correlated with the artery expansion during the stent deployment. The correlation is further used to predict the effect 
of a complex clinical procedure, such as stent overlapping, on the level of in-stent restenosis developed after percutaneous 
coronary intervention.
Keywords Finite element · In-stent restenosis · Stent deployment · Arterial damage · Tissue-growth model
1 Introduction
Atherosclerosis is a progressive vascular disease, resulting in 
the narrowing of lumen, compared to its healthy condition, 
due to the build-up of plaque inside an artery wall (Libby 
2002). The plaque development is caused by migration and 
proliferation of native cells and local accumulation of blood-
borne species, which include lipid, fibro-fatty composites 
and calcium salts (Singh et al. 2002). Percutaneous coronary 
intervention (PCI) is a minimally invasive surgical procedure 
to treat atherosclerotic arteries. The development of PCI 
started with angioplasty, for which a small balloon, inserted 
to the diseased part of an artery, is used to open the blocked 
artery through inflation. However, an acute vessel recoil 
often occurs after angioplasty. To eliminate the problem, 
stents, either balloon- or self-expandable, were developed 
and introduced to PCI, aiming to support the artery after 
expansion. The development of stents began with bare-metal 
stents (BMSs) and then progressed to drug-eluting stents 
(DESs) and bioresorbable vascular scaffolds (BVSs). BMSs, 
made of pure metals (no coating), were found to associate 
with a high occurrence of neointimal hyperplasia—enlarge-
ment of internal arterial layer—after implantation, leading to 
a re-narrowing of the treated artery, i.e., in-stent restenosis 
(ISR). To reduce the rate of ISR, polymer coatings, loaded 
with drugs that could inhibit neointimal growth, were intro-
duced to cover the metal struts, leading to the revolution-
ary development of DESs. Recently, BVSs, made of biode-
gradable polymers or metals, were developed for complete 
bioresorption after the implantation, with the hope of further 
reducing ISR as well as late stent thrombosis caused by the 
permanent presence of metallic stents.
ISR is one of the major issues for PCI and defined as a 
decrease in luminal diameter by more than 50% after stent 
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implantation (Hamid and Coltart 2007). The incidence 
of ISR (binary restenosis rate) for BMSs was found to be 
between 20 and 30%, based on medium- and long-term fol-
low-ups of clinical trials (Iqbal et al. 2013). DESs are asso-
ciated with a significantly reduced rate of ISR (% diameter 
stenosis (DS)) compared to BMSs. For example, the SPIRIT 
I trial showed that the rate and incidence of ISR for XIENCE 
V DESs were 16% and 0%, respectively, significantly lower 
than those (39% and 25.9%, respectively) for BMSs (Serruys 
et al. 2005). In ENDEAVOR II trial, the Endeavor DESs 
also demonstrated better outcomes than BMSs, in terms 
of the rate (27.8% for Endeavor vs. 42.3% for BMS) and 
incidence (9.5% for Endeavor vs. 33.5% for BMS) of ISR 
(Kandzari and Leon 2006). For BVSs, the ABSORB GT1™ 
(Abbott Vascular, USA) was the first, and also the only, stent 
that received both the European CE marking and US Food 
and Drug Administration approval. However, several inde-
pendent randomized controlled trials (RCTs) showed the 
ABSORB BVSs caused a higher ISR rate than DESs (Rizik 
et al. 2017), including ABSORB China (18.5% for ABSORB 
vs. 11.3% for DES), ABSORB Japan (17.4% for ABSORB 
vs. 11.7% for DES), EVERBIO II (16.9% for ABSORB vs. 
11.3% for DES) and TROFI II trials (17.3% for ABSORB 
vs. 14.5% for DES). In addition to stent technology, the pro-
cedure-related factors also pose a risk to the development of 
ISR, such as the number and length of stents being used and 
stent overlapping. Specifically, the implantation of multiple, 
longer and overlapped stents increased the occurrence of 
ISR (Hoffmann and Mintz 2000).
A brief description of the structure of, and the biological 
response to tissue damage in, arteries is given below to sup-
port the development of the mechanical model of resteno-
sis. A healthy arterial wall has three distinct layers, i.e., the 
intima, media and adventitia layers. The intima consists of 
one layer of endothelial cells, a subendothelial layer and an 
internal elastic lamina supporting the endothelium (Craw-
ford et al. 2009). The media, the middle layer of the artery 
wall, is made of smooth muscle cells (SMCs) and elastic col-
lagen fibrils. The adventitia, the outermost layer of the artery 
wall, is mainly composed of fibroblasts and fibrocytes, a 
histological ground substance and thick bundles of collagen 
fibrils forming a fibrous tissue. During the development of 
atherosclerosis, plaque forms in the intima layer and builds 
up between the endothelium and the media layer. As stent 
is in direct contact with plaque during the PCI procedure, 
it causes damage and rupture to the plaque as a result of 
expansion. On the other hand, mechanical stretching of the 
vessel wall also induces damage and injury to the media and 
adventitia layers, activating the transmigration of the leuco-
cyte into the vessel wall. This process triggers a proliferation 
of SMCs in the media layer, which then migrates to form 
neointima and thicken the vessel wall (Hoffmann and Mintz 
2000). Although the inflammatory events begin as beneficial 
wound-healing responses, an adverse vascular change hap-
pens in the end, leading to re-narrowing of the blood vessel, 
or ISR (Bennett and O’Sullivan 2001; Evans et al. 2008).
Hence, a correlation between the stenting-induced vessel 
injury and the rate of ISR has been investigated with patient 
and animal studies. For instance, stents were implanted into 
coronary arteries of pigs to examine the contributions of 
stenting-induced arterial injury and inflammatory response 
to neointimal hyperplasia (Schwartz et al. 1992; Kornowski 
et al. 1998). A level of arterial injury was found positively 
correlated with the inflammatory reaction and neointimal 
formation. In fact, monocytes, a type of leucocyte, were 
observed in rabbits implanted with endovascular metal 
stents. They adhered to the inner surface of stent-injured 
arteries and then penetrated the arterial wall, resulting in 
neointima formation (Rogers et al. 1996). Also, Farb et al. 
(2002) examined 87 stented coronary arteries taken from 56 
patients and showed that medial damage induced by coro-
nary stenting increased arterial inflammation, associated 
with an increased neointimal growth. Furthermore, Dussail-
lant et al. (1995) used volumetric intravascular ultrasound 
to assess the ISR in 44 patients treated with Palmaz-Schatz 
stents. It was found that the volume of neointimal hyperpla-
sia was greater in restenotic stents, and the pattern of ISR 
was related to the distribution of neointimal tissue.
Therefore, modelling-based studies were also attempted 
to correlate quantitatively the arterial damage and the ISR. 
For instance, agent-based model (ABM) has been used to 
simulate the SMC growth in response to the stent-induced 
damage obtained from FE analysis (Zahedmanesh et al. 
2014; Nolan and Lally 2018). The model demonstrated a 
direct correlation between the stent deployment diameter 
and the level of ISR. Coupled with FE analysis, the ABM 
was adopted by Keshavarzian et al. (2018) to model the 
response of vessels to the levels of growth factors, proteases, 
signalling molecules and blood pressure. The ABM was also 
applied for multiscale modelling of stent deployment, and 
subsequent blood flow and tissue growth in a stented vessel 
(Tahir et al. 2013, 2015; Zun et al. 2019, 2017), in agreement 
with in vivo post-stenting data. On the other hand, Holzapfel 
et al. (2000, 2002) developed a three-dimensional model 
for simulation of balloon angioplasty and stent deployment 
in a stenotic artery to gain a mechanistic understanding of 
the PCI procedure. Their results showed that stresses in a 
vessel wall were significantly localized and component-
specific, which might activate the migration and prolifera-
tion of SMCs and subsequently led to ISR. Lally and Pren-
dergast (2006) used a damage-adaptive finite element (FE) 
approach to simulate ISR for three different stent designs. 
Their results for ISR demonstrated that the restenotic growth 
was concentrated around the stent struts and greatest at the 
ends of the stents. However, plaque was not considered in 
their simulations, while the arterial wall was modelled as a 
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hyperelastic isotropic material, representing a critical limita-
tion. Very recently, Fereidoonnezhad et al. (2017) proposed 
a continuum tissue-growth model, which involved cellu-
lar changes in the arterial wall due to damage, for simu-
lation of restenosis. They implemented the model into the 
FE software Abaqus via a user-defined material subroutine 
(UMAT), which was verified against the results obtained 
from a MATLAB code. Then, the model was applied to 
simulate the development of restenosis after angioplasty, 
and the results matched clinical observations qualitatively. 
Cheng and Zhang (2019) presented a growth model simi-
lar to the one proposed by Fereidoonnezhad et al. (2017), 
but its growth factor was linked to the stress instead of the 
damage. The model was also used to simulate the arterial 
wall remodelling after stenting, using the FE method. Their 
results suggested that the volumetric growth of the artery 
wall tended to even out, lowering both the overall stress and 
the stress concentration.
The correlation between stenting-induced vessel injury 
and the rate of ISR has been investigated in the literature, but 
the findings relied only on empirical data for certain target 
vessels and stent types. These data were generated by either 
(1) measuring the lumen loss of stented arteries through 
intravascular ultrasound imaging (Hoffmann et al. 2002) 
and autoradiography (Clowes et al. 1989) or (2) defining an 
injury score based on histological sections which was cor-
related with the neointimal growth (Schwartz et al. 1992). 
However, so far, it was unable to correlate damage mecha-
nisms (including property and morphology changes) inside 
the arterial tissue with the load condition during and after 
PCI. Therefore, the relationship between the stress inside the 
vascular tissue and the resulting ISR is still not known. The 
contact pressure between the balloon/stent and artery causes 
vascular damage, manifested in the form of tissue softening, 
fibre rupture/reorientation, cell migration and proliferation 
and endothelial denudation. The harmful contact pressure 
depends on the area of the stent surface, the final diameter 
of the stent, expansion mechanisms of the stent and balloon, 
and the pressure inside the balloon. Clearly, the quantifica-
tion of vascular damage and ISR based on mechanical data 
has not yet been published, and this is a limitation of exist-
ing studies in modelling of vascular growth after PCI with 
stenting.
The aim of this paper is to investigate the contribution of 
tissue damage in the media layer to ISR after stent deploy-
ment, with a focus on predicting the development of ISR 
with time. In the current study, appropriate hyperelastic 
models were adopted to describe the damage of plaque and 
arterial layers caused by stent deployment. A tissue-growth 
model, associated with vessel damage, was introduced to 
predict the growth of the media layer, a major contributor to 
ISR. Systematic FE simulations were carried out to analyse 
the stenting procedure, quantify the tissue damage caused 
by stenting and predict the subsequent evolution of ISR 
over a defined time. In addition, different commercial stents 
were explored further to study the effects of stent design and 
material on ISR, and, more importantly, to establish a direct 
correlation between artery expansion and the rate of ISR. 
The correlation was then used to predict the evolution of ISR 
caused by stent overlapping, a more complex clinical proce-
dure. The novelty of this paper includes: (1) assessment of 
stenting-induced arterial damage during PCI, (2) prediction 
of ISR after PCI and (3) correlation of ISR with stenting-
induced arterial damage. In particular, the diseased artery 
was described by one of the latest anisotropic hyperelastic 
and tissue damage models during the simulations of PCI.
2  Constitutive models
To capture the complex mechanical behaviours of tissue 
components, a series of models was established to describe 
its constitutive behaviours together with the material proper-
ties of stent and balloon, used as inflate devices.
2.1  Hyperelastic model with damage for plaque
The first-order Ogden hyperelastic model (Ogden 1972) with 
Mullins effect (i.e., stress-softening or damage; Ogden and 
Roxburgh 1999) was used to describe the constitutive behav-
iour of the plaque (assumed to be isotropic), for which the 
pseudo-energy potential is given as:
where 휓vol and ?̄?0 are the volumetric and isochoric parts of 
strain energy, respectively, 휙(휂) is the smooth discontinuous 
damage function, 휇 , 훼 and D are the material parameters, J is 
the volumetric ratio, 휆1 , 휆2 and 휆3 are the principal stretches 
(ratios), the bar denotes isochoric values and the superscript 
0 refers to the primary loading path. In addition, 휂 ∈ [0, 1] is 
the damage variable expressed as:
where m and r are the positive parameters, erf() is the error 
function and ?̄?max denotes the maximum strain energy in 
the deformation history.
The model parameters were determined by fitting the 
experimental stress-stretch data obtained by Maher et al. 
(1)
𝜓 = 𝜓
vol
+ 𝜂?̄?0 + 𝜙(𝜂)
=
1
D
(J − 1)2 + 𝜂
2𝜇
𝛼2
(
?̄?𝛼
1
+ ?̄?𝛼
2
+ ?̄?𝛼
3
− 3
)
+𝜙(𝜂),
(2)𝜂 = 1 − 1
r
erf
[
1
m
(
?̄?max − ?̄?0
)]
,
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(2011) for echolucent plaque of human carotid artery, and 
the corresponding values are given in Table 1, where ρ is 
the density of the plaque with value given in Rahdert et al. 
(1999). The stress-stretch response for the plaque, simulated 
under the uniaxial tension, is shown in Fig. 1, demonstrat-
ing a good agreement with the experimental results (Maher 
et al. 2011).
2.2  Hyperelastic model with damage for arterial 
layers
The modified HGO-C model (Nolan et al. 2014) with dam-
age (Fereidoonnezhad et al. 2016) was used to describe the 
anisotropic hyperelastic constitutive behaviour of arterial 
layers, with a pseudo-energy potential given by
where ?̄?m and 휓0f ,훼 are the isochoric energy stored in non-
collagenous matrix and collagen fibres, respectively, 
휙f ,훼
(
휂f ,훼
)
 and 휙in
(
휂in
)
 are the damage functions for the Mul-
lins effect and permanent deformation, respectively, C10 and 
k1 are the stress-like parameters, k2 is the dimensionless 
parameter, 〈  〉  stands for the Macaulay brackets, 
휅(0 ≤ 휅 ≤ 1∕3) is the temperature-dependent material 
parameter describing the level of dispersion in the fibre 
directions, N is the number of families of fibres (N ≤ 3), I1 is 
the first principal invariant of the right Cauchy–Green defor-
mation tensor C (i.e., I1 = tr퐂 = 휆21 + 휆22 + 휆23 and its iso-
choric part is Ī1 = J−2∕3I1 ), I4(훼훼) are the invariants of C and 
퐚훼 (i.e., I4(훼훼) = 퐚훼 ⋅ 퐂퐚훼 , with 퐚훼 being the unit vectors used 
to define the mean directions of the fibres in the reference 
configuration). In addition, 휂f ,훼 and 휂in are the damage vari-
ables for the Mullins effect and permanent deformation, 
respectively, and 휓∗
in
(
I∗
i
)
 is the (anisotropic) inelastic energy 
dissipation, which are given by:
(3)
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,
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Ī∗
1
− 3
)
+
k∗
1
2k∗
2
N∑
𝛼=1
[
exp
(
k∗
2
⟨
𝜅∗
(
Ī∗
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,
Table 1  Parameter values of Ogden model with Mullins effect for 
plaque
ρ (t/mm3) 휇 (MPa) 훼 D  (MPa−1) r m (mJ/mm3)
1.22E−9 0.00396803 13.8367 0.239019 1.3 0.008
0
0.005
0.01
0.015
0.02
0.025
0.03
1 1.05 1.1 1.15 1.2 1.25 1.3
St
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ss
 (M
Pa
)
Stretch
(b)
(a)
Fig. 1  a Stress-stretch response of plaque simulated using Ogden 
model with Mullins effect, in comparison with experimental data 
for echolucent plaque in Maher et al. (2011) (unloading occurred at 
stretch levels of about 1.2, 1.3, 1.4 and 1.5); b a zoomed-in view of 
the low strain region
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where C∗
10
 , k∗
1
 , k∗
2
 and 휅∗ are the material parameters for per-
manent deformation, and Ī∗
1
 and I∗
4(훼훼)
 are the strain invariants 
at the peak deformation of the loading history (i.e., 
?̄?0
m
+ 𝜓0
f ,𝛼
=
(
?̄?m + 𝜓f ,𝛼
)max).
Again, the model parameters were determined by fit-
ting the experimental stress-stretch data for thoracic aortas 
(Weisbecker et al. 2012; Fereidoonnezhad et al. 2016). In 
this study, it was assumed that there were two families of 
fibres, embedded symmetrically in the tangential surface of 
each arterial layer, with 휑 representing the angle between the 
mean direction of fibres and the circumferential direction in 
the artery. The fitted parameter values are given in Table 2 
for the media and the adventitia layers. A VUMAT subrou-
tine, interfaced with Abaqus, was written for the modified 
HGO-C model with damage. The stress-stretch responses 
for the arterial layers, also simulated under uniaxial tension, 
are shown in Fig. 2, which are in good agreement with the 
corresponding results in Fereidoonnezhad et al. (2016). 
2.3  Growth model for media
The growth model used for simulating the neointima forma-
tion was adopted from Fereidoonnezhad et al. (2017), based 
on a consideration of an intermediate configuration between 
the reference and the current ones. Since the neointima for-
mation is associated with the inflammatory reaction to the 
stenting-caused damage in the media (Farb et al. 2002), the 
growth model was only applied to the media in the simula-
tions. The deformation gradient F is multiplicatively decom-
posed into an elastic part 퐅e and a growth part 퐅g:
Table 2  Parameter values of modified HGO-C model with damage for arterial layers (Fereidoonnezhad et al. 2016)
Media
ρ
(t/mm3)
C10
(MPa)
D
(MPa−1)
k1 (MPa) k2 휅 휑
(°)
1.066E−9 0.020 0.001 0.112 20.610 0.24 41.0
C
∗
10
 (MPa) k∗
1
(MPa)
k
∗
2
휅∗ r
f
m
f
 (MPa) m2
0.000529 0.001648 0.028 0.27 3.36 0.0151 3.03
Adventitia
ρ
(t/mm3)
C10
(MPa)
D
(MPa−1)
k1 (MPa) k2 휅 휑
(°)
1.066E−9 0.008 0.001 0.362 7.089 0.17 50.1
C
∗
10
 (MPa) k∗
1
(MPa)
k
∗
2
휅∗ r
f
m
f
 (MPa) m2
0.000333 0.001445 0.460 0.27 2.70 0.0200 2.23
0
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Modified HGO-C model with damage (circumferenal)
Modified HGO-C model with damage (longitudinal)
Simulaon results in Fereidoonnezhad et al. (2016) (circumferenal)
Simulaon results in Fereidoonnezhad et al. (2016) (longitudinal)
Fig. 2  Stress-stretch responses of media (a) and adventitia (b) simu-
lated using modified HGO-C model with damage, in comparison 
with those for thoracic aortas in Fereidoonnezhad et al. (2016) (black 
squares indicate unloading points)
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Substituting Eq. (10) into 흈 = 1
J
휕휓
휕퐅
⋅ 퐅T , we have
A specific form is required for the growth tensor 퐅g in 
order to fulfil the constitutive formulation. The growth of 
the anisotropic arterial tissue is expected to be anisotropic; 
however, as no experimental data are available to character-
ize the anisotropic neointimal growth, an isotropic growth 
tensor was adopted here and is expressed as:
where 휆g is the growth stretch.
Substituting Eq. (12) into Eq. (11) leads to
To associate with the damage parameter Dg in the modi-
fied HGO-C damage model introduced in Sect. 2.2, the 
growth stretch is proposed as (similar to the work of Ferei-
doonnezhad et al. (2017) and satisfies the continuity equa-
tion as given in “Appendix 2”):
with
where k and 훽 are the material parameters, and Dth is the 
threshold value for the growth to start. Since the accumu-
lation of neointimal hyperplasia tissue in human peaks at 
6 months after stent deployment (Hoffmann and Mintz 
2000), a time period of 6  months was chosen for tis-
sue growth in this study. The value of 훽 was chosen as 
0.05 days−1 so that the tissue growth was able to approach 
its maximum volume over 6 months. The value of k was 
chosen as 0.5 days−2 so that the ISR rate for the XIENCE 
Sierra could reach ~ 20% over 6 months which was close to 
the clinical follow-up (Serruys et al. 2005; Rizik et al. 2017). 
Also, it was assumed that the tissue would grow as soon as 
the damage exists, so Dth was taken as 0.
Again, a VUMAT subroutine was coded to realize the 
growth model in Abaqus/explicit computationally. To verify 
the subroutine, the simulation of angioplasty in Fereidoon-
nezhad et al. (2017) was repeated, using exactly the same 
FE set-up and the models of tissue damage and growth for 
arterial layers (see “Appendix 1”). Basically, a subroutine 
was programmed for the same tissue-growth model as that 
(10)퐅 = 퐅e퐅g.
(11)흈 = 퐅−1g 흈e퐅−Tg .
(12)퐅g = 휆g퐈,
(13)흈 = 흈e∕휆2g.
(14)
휆g =
N∏
훼=1
√
휆g,훼 =
N∏
훼=1
exp
{
k
6훽2
[
1 − (1 + 훽t)e−훽t
]
Dg,훼 − D
th
}
,
(15)Dg,𝛼 =
1
rf
erf
(
?̄?max
f ,𝛼
mf
)
.
in Fereidoonnezhad et al. (2017), and the simulation results 
matched the work of Fereidoonnezhad et  al. (2017), as 
shown in Fig. 16 in “Appendix 1”. This independent exercise 
verified the numerical algorithm used for coding the subrou-
tine. Then, the subroutine was modified by adopting a new 
growth stretch proposed in this study for the ISR simulation 
(i.e., Equation (14)).
Continuum-based tissue-growth models, different from 
the model in Fereidoonnezhad et al. (2017), also exist in the 
literature. For instance, Boyle et al. (2011, 2013) proposed 
a mechanobiological model and used a lattice-modelling 
approach to simulate the development of ISR. The model 
was able to quantify the volume of neointima hyperplasia 
and give a quantitative comparison between different stents. 
Escuer et al. (2019) developed another damage-related volu-
metric growth model, in terms of densities/concentrations of 
important species such as growth factors, matrix metallopro-
teinases, extracellular matrix and contractile and synthetic 
SMCs. This model was used to simulate the development of 
ISR, and the results suggested that the arterial wall response 
was driven by the damage area, proliferation of SMCs and 
the collagen turnover. In addition, a so-called ghost mesh 
was used to simulate the neointimal remodelling procedure 
after stent deployment (Boland et al. 2016, 2019). However, 
stenting procedure was not simulated due to the complexity 
of generating the ghost mesh. Instead, the stent was mod-
elled in expanded condition and the artery was expanded 
by pressure loading. In our study, the model proposed by 
Fereidoonnezhad et al. (2017) was chosen as it can simulate 
the tissue-growth behaviour within a finite element frame-
work, thus allowing for a natural integration with the stent-
ing simulation step.
2.4  Material models for stent and balloon
In this paper, XIENCE Sierra (Abbott Vascular, USA), 
Endeavor (Medtronic Vascular, USA) and ABSORB 
GT1™ stents (Abbott Vascular, USA) were considered. The 
XIENCE Sierra and Endeavor stents were made of Co–Cr 
L605, with a density of 9.12E−9 t/mm3, the Young’s modu-
lus of 222,000 MPa and the Poisson’s ratio of 0.29. The 
plastic behaviour of Co–Cr alloy was provided in Poncin 
and Proft (2004). A semi-compliant balloon used to inflate 
the Co–Cr stents was assumed to be made of Pebax 7233, 
with a density of 1.01E−9 t/mm3, the Young’s modulus of 
510 MPa and the Poisson’s ratio of 0.30 (MatWeb 2018). 
The ABSORB stent was made of biodegradable PLLA, 
with a density of 1.4E−9 t/mm3, the Young’s modulus of 
2200 MPa and the Poisson’s ratio of 0.3 (Schiavone et al. 
2016). The plastic behaviour of PLLA was described by 
the stress–strain response measured by Pauck and Reddy 
(2015). The compliant balloon used to inflate ABSORB 
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was assumed to be made of polyoctanediol-co-citrate 
(POC), with a density of 1.1E−9 t/mm3, the Young’s modu-
lus of 49.79 MPa and the Poisson’s ratio of 0.31 (Ponkala 
et al. 2012). To investigate the effects of stent materials, a 
316L stainless steel was also considered, with a density of 
7.95E−9 t/mm3, the Young’s modulus of 193,000 MPa and 
the Poisson’s ratio of 0.27. The plastic stress–strain behav-
iour was provided in Poncin and Proft (2004). The engineer-
ing stress–strain relationships of Co–Cr, stainless steel and 
PLLA are compared in Fig. 3.
3  Finite element simulations of stenting 
and in‑stent restenosis
3.1  Models for artery, plaque, stents and balloon
A two-layer coronary artery (a general coronary artery 
instead of a specific one), with an overall wall thickness of 
0.66 mm, an inner diameter of 3 mm and a length of 40 mm, 
was modelled. Specifically, the artery consisted of an adven-
titia and a media layer, with a wall thickness of 0.34 mm and 
0.32 mm, respectively (Holzapfel et al. 2005). An extremely 
thin intima layer was not considered in the simulations due 
to its negligible contributions to artery deformation. Specifi-
cally, for young healthy adults, the intima usually consists 
of one or two layers of endothelial cells and has a thickness 
of 2–4 µm (Crawford et al. 2009; the intima thicknesses 
may increase slightly with age). As discussed in Holzapfel 
et al. (2005), the intima layer intends to thicken throughout 
the human life, and the “thickened intima” is believed to be 
neointima, instead of a healthy intima layer. In our work, the 
stenotic artery was considered as a healthy artery with accu-
mulated plaque. The plaque was modelled as a symmetric 
layer inside the artery, with a length of 10 mm and a stenosis 
of 50% (i.e., an inner diameter of 1.5 mm). Hexahedral ele-
ments with reduced integration (C3D8R) were used to mesh 
the artery and the plaque. It should be noted that Abaqus 
explicit, used in this work, does not support incompressible 
hyperelastic materials or hybrid elements, and thus, hybrid 
elements could not be used here. In the radial direction, the 
artery was meshed with four rows of elements for each tissue 
layer, and the plaque was meshed with 8 rows of elements. 
In the longitudinal direction, a bias control was used to mesh 
the artery, allowing for a gradual increase in the element size 
towards both ends of the artery. The FE model for the artery 
and plaque is shown in Fig. 4a.
FE models for the XIENCE Sierra, Endeavor and 
ABSORB stents were built using Abaqus CAE as shown in 
Fig. 4b; all three stents had a length of 12 mm and an outer 
diameter of 3 mm. The strut thicknesses of the XIENCE 
Sierra, Endeavor and ABSORB were 81 µm, 91 µm and 
150 µm, respectively. The tri-folded balloon, used to inflate 
the stents, had a length of 16 mm and a diameter of 3.2 mm 
in a fully inflated shape. NX 8.5 (Siemens PLM Software, 
UK) was used to create the tri-folded balloon model. Spe-
cifically, a series of cross-sectional sketches were created 
on four uniformly distributed datum planes in fully folded 
configuration. These cross-sectional sketches were then 
extruded to produce the 3D geometry by using the sweep 
tool. Then, the 3D geometry was imported into Abaqus CAE 
to produce the final geometry of tri-folded balloon model 
(see further details in Qiu et al. (2018)). The use of tri-folded 
balloon was also recommended by Bukala et al. (2017) and 
Geith et al. (2019) in order to obtain reliable results in FE 
simulations of stent expansion. In Abaqus, C3D8R and 
M3D4R (three-dimensional 4-node membrane elements 
with reduced integration) were used to mesh the stents and 
the balloon, respectively. The stents and the balloons were 
firstly crimped by 12 rigid plates to fit in the diseased artery 
as shown in Fig. 4c. Specifically, radial displacements were 
applied to the rigid plates to crimp the stents, along with the 
balloon, to an outer diameter of 1.3 mm.
Mesh sensitivity was systematically carried out in our 
previous studies, in terms of stent deployment (Schiavone 
2015; Qiu 2017). For the stent, four different meshes, 
namely 2 × 2, 2 × 4, 4 × 4 and 6 × 6 layers of elements across 
the width and thickness, were compared. For the artery, also 
four different meshes, namely 1, 2, 4 and 6 rings of elements 
across the wall thickness, were compared for each arterial 
layer. The simulations showed a good convergence, in terms 
of stress distribution and maximum/average stress values, for 
the stent meshed with 4 × 4 layers of elements and the artery 
layer meshed with 4 rings of elements through the thickness 
direction. Therefore, in this study, 4 × 4 layers of elements 
were used for stent strut and four rings of elements were 
used for the arterial layer. The plaque was meshed with 8 
rings of elements, twice those for each arterial layer as rec-
ommended in Schiavone (2015). This mesh was sufficiently 
Fig. 3  Engineering stress–strain curves of Co–Cr, stainless steel and 
PLLA
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fine to capture the variation of damage and ISR across the 
vessel layer (as shown in Figs. 7 and 9).
3.2  Boundary and loading conditions
Both ends of the artery were fully fixed throughout the simu-
lations to reflect the constraints imposed by the human–body 
environment. The process of stent deployment in the diseased 
artery consisted of balloon inflation, deflation and removal 
steps. The inflation step was performed by applying pres-
sure on the inner surface of the balloon. The pressure was 
increased linearly from 0 to 12 atm (1.216 MPa, within the 
recommended pressure ranges of all the three stents), with the 
balloon fixed at both ends. Interactions between the artery, the 
stent and the balloon were modelled as general hard contacts 
with a frictional coefficient of 0.25 (Ju et al. 2008). A balanced 
master–slave weighting and finite-sliding formulation were 
used for all the contact simulations. For balanced master–slave 
contact, Abaqus/Explicit calculates the penalty forces twice for 
surfaces in contact, where the two surfaces act as the master 
surface in turn for each calculation. The weighted average of 
the two penalty forces is then applied to the contact interaction. 
The finite-sliding formulation allows for arbitrary separation, 
sliding and rotation of the surfaces in contact. Subsequently, 
the deflation step was modelled by releasing the pressure on 
the inner surface of the balloon, allowing the expanded stent to 
recoil freely. Interactions between the stent, balloon and artery 
were maintained in this step. In the balloon-removal step, con-
tact of the balloon with the stent and artery was removed. In 
the tissue-growth step (6 months), the media began to grow 
based on the damage caused by the stent deployment. The stent 
was not included in this step as the model is unable to simulate 
Fig. 4  Finite element mod-
els: a coronary artery-plaque 
assembly; b XIENCE Sierra, 
Endeavor and ABSORB stents 
with zoomed-in views; c 
balloon-stent assembly with 12 
rigid plates
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(c)
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the growth of tissue over the stent. All simulations were car-
ried out using the Abaqus explicit solver (Dassault Systèmes 
2017). Each of them took 48 cores (Westmere Xeon X5650 
CPUs at 2.66 GHz) in the cluster of Loughborough University 
and took about 4 days to finish.
4  Results
4.1  Deformation during stent deployment
The outer diameter of the stent was tracked during the 
stenting process and is plotted in Fig.  5a against the 
applied pressure. Generally, the stent diameter increased 
slightly at the beginning, followed by a rapid increase 
and then a steady state with the further increase in pres-
sure. The three stents experienced different rates of 
expansion during balloon inflation. The XIENCE Sierra 
and Endeavor stents showed similar expansion behaviour 
and reached a steady state at a pressure of around 0.3 MPa, 
while the ABSORB stent expanded with a lower rate and 
reached a steady state at a pressure of around 0.5 MPa. The 
peak diameter achieved by the XIENCE Sierra, Endeavor 
and ABSORB stents at the maximum inflating pressure 
was 3.25 mm, 3.30 mm and 3.38 mm, respectively. After 
the deflation, the stent diameter experienced a gradual 
decrease, leading to a recoiling effect. The final diameter 
was 3.11 mm, 3.06 mm and 3.03 mm for the XIENCE 
Sierra, Endeavor and ABSORB stents, respectively. Clini-
cal trials showed that the lumen gain for the XIENCE stent 
was greater than that for the Endeavor stent (Serruys et al. 
2010), consistent with our results. Also, most ABSORB 
RCTs (e.g., ABSORB II, ABSORB China, ABSORB 
Japan, ABSORB III, EVERBIO II) showed less lumen 
Fig. 5  a Evolution of outer 
diameter with pressure for 
XIENCE Sierra, Endeavor and 
ABSORB in stenting; b equiva-
lent plastic strain in stents after 
deployment
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gain for ABSORB stent when compared to metal stents 
(Rizik et al. 2017), which confirms our results as well. In 
addition, the equivalent plastic strain in the stents after 
deployment is plotted in Fig. 5(b). It can be seen that the 
plastic deformation was dominantly located at the U-bend 
regions in all three stents. The maximum equivalent plastic 
strain for the XIENCE Sierra stent was slightly higher than 
that for the Endeavor stent (i.e., 0.21 for XIENCE Sierra 
vs. 0.18 for Endeavor), while that in the ABSORB stent 
was even higher (1.43), reflecting the weak properties for 
PLLA. All three stents showed dog-boning and asymmetri-
cal cell expansion, which affected the stress/strain peaks 
and overall expansion as shown in Fig. 5.
In addition, the maximum principal stress developed in 
the media layer at peak inflating pressure is plotted in Fig. 6 
against the longitudinal position, where the origin is taken as 
the plaque’s centre. The symbols are data retrieved from the 
integration points inside the media layer (also for the rest), 
which vary across the thickness direction of each layer (inner 
to outer positions). Corresponding contour plots are also 
presented to demonstrate the distribution of the maximum 
principal stress. Here, the results are shown for the media 
layer only as they are directly related to the tissue growth 
and development of ISR. The maximum principal stresses 
decreased from the inner to the outer radii of the media. The 
stresses in the media were at a similar level for the XIENCE 
Sierra and Endeavor stents, while higher stresses were 
noticed for the ABSORB stent due to the larger expansion. 
Since the plaque thickness decreased towards both ends, the 
stenting-induced stresses in the media layer also decreased 
at the ends of the plaque. Similar behaviour was also found 
for the stresses developed in the plaque and the adventitia 
layer. The stress distribution in Fig. 6a is asymmetric, mainly 
due to asymmetrical deformation of the stent. However, the 
asymmetricity is not significant according to the longitudinal 
distribution plot (left picture of Fig. 6a).
4.2  Tissue damage and development of in‑stent 
restenosis
Here, dissipation energy (density) was used to quantify the 
damage in the tissue caused by stenting. Similarly, the dis-
sipation energy in the media layer after stenting is plotted 
in Fig. 7 against the longitudinal position, together with the 
corresponding contour plots. Again, the symbols are data 
retrieved from the integration points inside the media layer, 
which vary across the thickness direction of each layer (inner 
to outer positions). As shown in Fig. 7, the Endeavor stent 
caused more damage to the media layer than the XIENCE 
Sierra stent. The ABSORB stent introduced the highest level 
of damage to the media layer, as indicated by the maximum 
value of dissipation energy (Fig. 7c), which is about 1.5 
times higher than that caused by the two metallic stents 
(Fig. 7a, b). The points are separated into several distinct 
groups by dissipation energy. With a closer look, the gaps 
are also observed for the maximum principal stress plot 
(Fig. 6), although not as significant as the dissipation energy. 
This is simply because the hyperelastic behaviour of vessel 
tissue (i.e., highly nonlinear) and the gaps for the dissipa-
tion energy and the maximum principal stress do not follow 
a linear scaling relationship. Specifically, a small variation 
in the maximum principal stress can be amplified in the dis-
sipation energy.
The change of lumen diameter was adopted to represent 
the ISR level. This diameter was obtained by tracking and 
averaging the radial displacements of all the nodes on the 
inner surface of the plaque. The change of lumen diameter 
in the stenting and tissue-growth steps for the XIENCE 
Sierra, Endeavor and ABSORB stents is compared in 
Fig. 8. The lumen was expanded to a similar diameter 
for the XIENCE Sierra, Endeavor and ABSORB stents 
(i.e., 3.14 mm, 3.16 mm and 3.19 mm on average, respec-
tively) at the end of inflation (Fig. 8a). After 6 months of 
stent implantation, the mean lumen diameter reduced to 
2.39 mm, 2.20 mm and 1.83 mm for the XIENCE Sierra, 
Endeavor and ABSORB stents, respectively (see Fig. 8b). 
The growth stretch 휆g of the media layer after 6 months of 
stent implantation was more localized for the Endeavor 
stent and had a higher maximum value when compared 
to that for XIENCE Sierra stent (Fig. 9). For both metal-
lic stents, the growth stretch was concentrated in the area 
in contact with the U-bends of the stent. Also, for the 
Endeavor stent, the growth stretch became more signifi-
cant at the locations where the two U-bends were con-
nected (see red regions for Endeavor in Fig. 9b). For the 
ABSORB stent, the growth stretch 휆g of the media layer 
had a maximum value of 36,539, the highest among the 
three stents studied and around 15 times that for the two 
metallic stents.
4.3  Effects of stent materials on tissue damage 
and in‑stent restenosis
As shown in Sects. 4.1 and 4.2, both the stent design and 
material have an impact on the tissue damage and the ISR 
rate following stent implantation. To separate these effects, 
an additional study on the effects of stent materials on ISR 
was performed by considering a stent with the same design 
as the XIENCE Sierra stent but made of the Co–Cr alloy, 
316L stainless steel and PLLA. In order to achieve the same 
expansion at the end of inflation, a linear-elastic tube con-
trolled by cosinusoidal velocity was used to expand the 
stents to the same diameter of 3.0 mm. As shown in Fig. 10, 
the damage in the media layer appeared to be the least for 
PLLA and the most for Co–Cr. Since the stainless steel and 
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Fig. 6  Longitudinal distributions and longitudinal and cross-sectional contour plots of maximum principal stresses (MPa) in the media layer at 
maximum pressure in deployments of a XIENCE Sierra, b Endeavor and c ABSORB
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PLLA stents recoiled much more than the Co–Cr one as 
shown in Fig. 11(a), the difference of the lumen diameters 
between day 0 and month 6 was used to compare the sever-
ity of the ISR. It can be seen that, for Co–Cr alloy, the ISR 
was significantly higher than those for the stainless steel 
and PLLA. Specifically, the rate of ISR was computed as 
19.52%, 2.92% and 0.53% for Co–Cr, stainless steel and 
PLLA, respectively, indicating that Co–Cr caused more 
severe ISR than stainless steel and PLLA. This was also 
confirmed by the contour plots of the growth stretch 휆g in 
the media at month 6 (see Fig. 12). The maximum value of 
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휆g for Co–Cr was 1.55 and 3.75 times higher than those for 
stainless steel and PLLA, respectively.
4.4  Correlation of artery expansion with in‑stent 
restenosis
Based on the results above, it seems that the expansion of 
the artery achieved at peak inflating pressure during stent-
ing determines the amount of tissue damage induced to the 
media layer, and it was assumed the development of ISR 
is caused by the tissue damage in the media layer. Here, 
the dissipation energy of the media layer within the dis-
eased region of the artery was used to represent the amount 
of tissue damage introduced to the media layer by stent-
ing. The lumen diameter achieved at peak inflating pres-
sure was taken to represent the maximum expansion of the 
artery during stent implantation, while the lumen diameter 
at 6 months was used to represent the level of ISR after 
stent implantation. From the simulations conducted for 
the XIENCE Sierra, Endeavor and ABSORB stents, data 
were extracted at ten different sections for each stent. These 
sections were evenly distributed in the diseased part of the 
artery along the longitudinal direction. For each section, the 
value of the dissipation energy was averaged over two inte-
rior rings of elements in the media layer, while the lumen 
diameter was averaged over the nodes on the inner surface 
of the plaque and shared by the two rings of elements. The 
extracted lumen diameters at peak inflating pressure and 
after 6 months of stent deployment are plotted in Fig. 13a, b, 
respectively, against the extracted dissipation energy in the 
media layer caused by stenting. Apparently, the dissipation 
energy in the media layer has a positive linear correlation 
with the maximum lumen diameter achieved during stent 
deployment, while it has a negative linear correlation with 
the lumen diameter after 6 months of stenting. It can be 
confirmed that an increase in artery expansion causes an 
increase in damage in the media layer, subsequently leading 
to the development of more ISR. Additionally, the lumen 
diameter during the tissue growth is plotted in Fig. 13c as 
a function of both the maximum lumen diameter and the 
growth time, showing a direct correlation of the ISR with the 
maximum lumen diameter over the time after stent implan-
tation. The diagram represents a 3D surface plot of ISR as 
a function of peak lumen diameter and time, which can be 
used directly to predict ISR for a given peak lumen diameter 
and time point. The lumen diameter (on the vertical axis) is 
negatively correlated with the maximum lumen diameter at 
0 days, which is opposed to what one would expect (i.e., a 
higher initial lumen diameter for the higher maximum infla-
tion diameter). This is because the correlation diagram was 
constructed from the results obtained using three different 
stents. For instance, at 0 days, simulations gave lower initial 
lumen diameter for ABSORB due to more recoiling effect 
even though its peak lumen diameter was larger when com-
pared to metallic stents. If the same stent was used, higher 
initial lumen diameter would always correspond to higher 
maximum inflation diameter.
4.5  Prediction of in‑stent restenosis for stent 
overlapping
In this section, the correlation diagrams presented in Fig. 13 
was used to predict the ISR developed after deployment of 
overlapped stents. For the simulation of overlapped stents, 
two XIENCE Sierra stents and associated balloons were 
modelled, with a length of 7 mm and 11 mm, respectively. 
The stents overlapped by 2 mm as shown in Fig. 14a. During 
the deployment process, Stent 1 was inflated first and had no 
interaction with Stent 2. When Stent 1 was in deflation step, 
the inflation for Stent 2 began and the interaction between 
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Fig. 9  a Longitudinal distri-
bution and b contour plots 
of growth stretch 휆
g
 in the 
media layer at 6 months after 
deployment of XIENCE Sierra, 
Endeavor and ABSORB stents
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the two stents was activated. Evolution of the lumen diam-
eter during stenting is plotted in Fig. 14b, showing the data 
extracted for all the nodes on the inner surface of the plaque 
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as well as the mean value (line). Substituting the averaged 
maximum lumen diameter of 3.11 mm into the correlation 
diagram in Fig. 13c results in the predicted lumen diam-
eter over 6 months of tissue growth, plotted in Fig. 14c as a 
dashed dark-green line. Simulations were also carried out to 
evaluate the ISR caused by stent overlapping, and evolution 
of the lumen diameter during the tissue-growth stage is also 
plotted in Fig. 14c. Clearly, the prediction and simulations 
are in a very good agreement. In addition, simulation for a 
single stent was also carried out and the result is plotted in 
Fig. 14) as solid red line, indicating the development of more 
severe ISR for a single stent in this situation.
Dissipation energy in the media layer obtained from the 
simulations of overlapping stents is plotted in Fig. 15a. Also, 
it is seen that they caused less damage in the media layer 
than a single stent (Fig. 7a). Furthermore, the maximum 
stenting-induced damage in the media layer was located in 
the middle region of Stent 2 (Fig. 15a, towards the right 
end). It should be noted that the two stents were expanded 
one after the other, instead of simultaneously. Also, both 
stents were shorter than the plaque and their overlap region 
was considerably stiffer than a single stent, so it was actually 
harder to expand two overlapped stents. Therefore, the over-
all deformation of the artery for the two overlapped stents 
was less than that for a single stent, causing less damage in 
the media layer.
5  Discussion
This study attempted to quantitatively correlate the stent-
ing-induced damage with the ISR. Clinical studies observed 
that the major mechanism of ISR was intimal hyperplasia 
(Hoffmann et al. 1996), a result of proliferation and migra-
tion of SMCs from the media layer, distributed over the 
whole length of the stent. Such proliferation and migration 
are healing reactions of the vessel wall to the injury of the 
media layer caused by stenting. Therefore, it is important 
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to understand the stenting-induced damage in the media 
layer and its contribution to the ISR. Here, a growth model 
associated with the tissue damage was adopted to describe 
the tissue-growth behaviour and applied to the medial layer 
to simulate the narrowing of the vessel after stent implan-
tation. The growth model was based on the multiplicative 
decomposition of the deformation gradient into an elastic 
and a growth part, with the latter associated with the geom-
etry changes that the tissues underwent after stenting due to 
proliferation and migration of SMCs. A connection between 
ISR and stenting-induced geometry changes was provided by 
this growth model. It should be noted that the growth part of 
the deformation gradient describes the increase in the vol-
ume of the tissue caused by the proliferation and migration 
of SMCs. The phenomenon was modelled from a mechan-
ics point of view and unable to model the infiltration of the 
SMCs into the lumen and the subsequent proliferation. Also, 
we are not sure how to relate the growth stretch with cell 
cycle length and population doubling time of SMCs directly. 
Nevertheless, the simulated rates of ISR were about 20–30% 
over 180 days, close to those reported in clinical trials that 
we reviewed in Introduction.
The damage is determined by the maximum strain energy 
and depends on the loading history. In our simulations, tis-
sue damage, in terms of energy dissipation, accumulated 
during the balloon inflation or stent expansion. During the 
subsequent simulation of tissue growth, it was assumed to 
remain unchanged and no further damage was introduced. 
So, tissue damage was primarily caused by stenting. Assess-
ment of stenting-induced damage in the arterial wall pro-
vided quantifiable and insight information of tissue injury 
following the stent treatment, aiding a better understanding 
of ISR development in patients. As demonstrated above, 
there is a direct correlation between the arterial damage and 
the ISR. In fact, our results showed that the maximum lumen 
diameter achieved during the stenting procedure, i.e., the 
lumen diameter achieved at peak inflating pressure, signifi-
cantly affected the rate of ISR. These findings are additional 
to a stress-based damage variable suggested in Zahedmanesh 
and Lally (2009), highlighting the significance of diameter 
expansion in ISR. This is also supported by the ISAR-STE-
REO clinical trial results (Kastrati et al. 2001). Basically, 
the DS immediately after the procedures showed that the 
thin-strut group had less optimal lumen gain, but this was 
found to have significantly reversed at 6-month follow-up 
(Kastrati et al. 2001).
Furthermore, this study investigated the effects of stent 
design and materials on ISR using FE simulations. Currently, 
the XIENCE Sierra and the Endeavor stents are the two most 
advanced DESs on the market thanks to their loaded drugs 
and stent designs. However, it was reported that, although 
they were deployed with similar inflating pressure, the mean 
DS at 1-year follow-up (21.3%) for the Endeavor stent was 
greater than that (15.2%) for the XIENCE stent (Akazawa 
et al. 2014). Hence, it is possible the Endeavor stent tends to 
result in more severe ISR than the XIENCE stent based on 
the clinical follow-up, as also confirmed by our simulation 
results. The Endeavor stent has a more flexible design than 
the XIENCE Sierra stent, which leads to a larger expansion 
of the artery under the same inflating pressure (Schiavone 
et al. 2014), introducing more damage to the media layer 
and, hence, more severe ISR. The ABSORB stent is at the 
cutting edge of stent development and aims for complete 
bioresorption after the implantation. Several RCTs, such as 
ABSORB II (Serruys et al. 2015), ABSORB III, ABSORB 
Japan (Kimura et al. 2015), ABSORB China and EVERBIO 
II (Sabaté et al. 2016), were carried out to study the mid- 
and long-term safety and performance of ABSORB stents. 
Rizik et al. (2017) compiled a pooled analysis of these RCTs 
and reported a significantly increased DS for the ABSORB 
stent when compared to that for the XIENCE metallic stent. 
This agrees with our simulation results, and there are two 
major reasons for this adverse outcome. First, the poly-
meric ABSORB stent is easier to expand during deployment 
thanks to its lower mechanical properties, resulting in larger 
expansion of the artery, more damage to the media layer and 
increased level of ISR. Second, ABSORB stent has a bulkier 
strut design, which prolongs the vessel-wall injury and slows 
down the arterial healing process when compared to stents 
with thinner struts (Nakazawa et al. 2009).
As another result of this study, diagrams of linear cor-
relations between the stenting-induced tissue damage in 
the media layer with the deformation of the artery and the 
level of ISR were produced. These diagrams can be adjusted 
by employing parameter values for the growth model cali-
brated against new experiments and used to predict the risk 
of ISR for patients. Quantifying the vascular damage can be 
regarded as one of the advantages of computational model-
ling, which is currently a challenge for in vitro, in vivo and 
clinical studies. However, parameters, which can be meas-
ured physically, may be considered as clinical predictors for 
the occurrence of ISR, such as the peak lumen diameter sug-
gested in this study. Basically, if the maximum lumen diam-
eter during the stenting procedure can be measured in the 
clinical setting, it can be used as input for the correlations to 
obtain the stenting-induced damage in the media layer and, 
subsequently, the ISR rate. However, in the reports of the 
several reviewed RCTs, none of them measured the maxi-
mum lumen diameter during the stenting procedure. Also, 
the maximum lumen diameter is closely related to the bal-
loon to artery ratio and inflation pressure, and it is generally 
accepted that a higher balloon to artery ratio results in higher 
rates of restenosis. In fact, some animal studies specifically 
used overinflated balloons to induce restenosis (Iqbal et al. 
2016). Carrozza et al. (1992) suggested several predictors 
for ISR in their study, such as lumen diameter after stenting, 
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but did not consider the maximum lumen diameter during 
the stenting procedure. It is not clear whether it is due to 
the limitation of the current medical imaging techniques or 
a lack of clinical data in correlating the maximum lumen 
diameter achieved during stenting with the ISR rate. Nev-
ertheless, our results indicated a strong correlation between 
the artery expansion caused by stenting and the evolution 
of ISR, which can be considered as a potential predictor 
for ISR in future clinical studies. Although the maximum 
lumen diameter was suggested here, it should be noted that 
the ISR can also be influenced by other factors such as stent 
type and the target vessel which need to be investigated in 
future work.
The high elastic modulus gives Co–Cr excellent radial 
strength when used in stents (Mani et al. 2007). Since the 
thickness of the struts is a significant concern in stent design 
as mentioned above, its ability to make ultra-thin struts with 
increased strength attracts attentions. A 316 stainless steel 
was the most common-used metal for stents due to its well-
suited mechanical properties and excellent corrosion resist-
ance. However, non-MRI compatibility, poor visibility in 
fluoroscopy and potential allergic reactions limit its clini-
cal usage. Studies showed that vessel healing completed in 
3–9 months (Williams and Awan 2017), after which the 
stents were not needed to hold the vessel any longer. This 
led to the development of bioresorbable polymeric stents, 
which were expected to be fully resorbed in a relevant 
period of time. However, some studies showed that biode-
gradable polymers induced additional inflammatory reac-
tions. From a mechanics point of view, our study indicated 
that softer materials such as polymer caused a lower tissue 
growth of the vessel wall than stiffer ones such as metallic 
alloys. However, due to the weaker mechanical properties of 
softer materials, the stent design has to be bulkier in order 
to achieve sufficient mechanical strength, which overlays 
the advantage of the material choice and can lead to the 
development of more severe ISR, as proved by the simula-
tion results in Sects. 4.1 and 4.2. In our opinion, in addi-
tion to high biocompatibility, two aspects are critical for a 
successful bioresorbable stent, i.e., mechanical properties 
and absorption time. We are aware that ABSORB has been 
pulled from the market, due to the clinical problems such 
as the increased incidence of thrombosis associated with 
the weaker mechanical properties of PLLA. Magmaris scaf-
fold made of magnesium alloy seems to be more successful 
in terms of mechanical properties, but it degrades too fast. 
So, for a better bioresorbable stent, it is critical to tailor the 
degradation rate, as well as control the change of mechanical 
properties, of bioresorbable stents through novel material 
processing and optimal structural design, with validation 
against thorough in vitro and in vivo studies.
According to the manufacturers’ instructions, it is recom-
mended that, for stent deployment, the inflation and deflation 
of the balloon should be performed within tens of seconds. 
However, for all simulations in this study, the step time for 
balloon inflation and deflation was set to be 0.1 s, i.e., sig-
nificantly shorter than those recommended. This is due to 
the constraints on the computational time of the simulations. 
For instance, simulation times would be increased by a factor 
of 20 if the inflation and deflation times are taken as of 1 s, 
i.e., an increase of 10 days in actual computing times. This 
would become unrealistic for the simulations carried out in 
this study. Still, the simulations for balloon-inflation times 
of 0.1 s and 1 s were compared, and the results were within 
5% difference in terms of the lumen diameter and stress dis-
tributions. Another limitation of this study is related to the 
experimental data used for constitutive-model calibration. 
The data for the plaque in Maher et al. (2011) were obtained 
from the unconfined cyclic compression, instead of tension, 
tests on specimens from the human carotid atherosclerotic 
plaque, and it is worthwhile to point out that the plaque 
might behave differently under tension. The parameters for 
the modified HGO-C model with damage were calibrated 
against the experimental data for the thoracic aorta instead of 
the coronary one. Another limitation is that the same balloon 
and the same pressure were used for all three stents simulated 
in this study. However, in reality, different pressures might 
be used for varied stent deigns which should be taken into 
account when assessing the design effects. These limitations 
should be noted when interpreting the simulation results pre-
sented in this work. In addition, the artery model was ideal-
ized with a uniform and symmetric plaque layer, while, in 
reality, the plaques might be asymmetric, discontinuous and 
diffused in the lumen. Hence, patient-specific cases should 
be explored in the future, based on high-resolution medical 
imaging of actual diseased artery. Also, for ABSORB, the 
impact of degradation on the vessel was not considered in 
this study. From the literature, ABSORB stent only begins to 
degrade six months after it is placed in the artery and is fully 
dissolved between 2 and 3 years or even beyond (Naseem 
et al. 2019; Serruys et al. 2014). So, the effect of degradation 
is expected to be very limited over 6-month period of times. 
Nevertheless, future work is required in order to understand 
the combined effects of vessel injury and stent degradation 
on the development of ISR.
6  Conclusions
A tissue-growth model, linking the stent-induced tissue 
damage and the ISR, was introduced and employed together 
with the FE approach to simulate the development of ISR 
after PCI. The numerical simulations carried out in this 
study demonstrated that the ABSORB stent resulted in more 
severe ISR than the XIENCE Sierra and Endeavor stents, 
Mechanistic evaluation of long-term in-stent restenosis based on models of tissue damage and…
1 3
which was also confirmed by clinical trials. Regarding the 
materials used for manufacturing stents, the ISR for softer 
materials was lower than that for harder ones. However, for 
polymeric stents, such benefit might be cancelled out by 
the requirement of bulkier stent design to meet the strength 
requirements. Correlation diagrams that could be potentially 
used for predicting the ISR were constructed from a series 
of FE simulations, confirming a direct correlation between 
the artery expansion and the ISR. Specifically, the maximum 
lumen diameter achieved during the stenting procedure is 
linearly correlated with the stenting-induced damage in the 
media layer and the development of ISR in the vessel, sug-
gesting that it can be considered as a clinical predictor for 
the occurrence of ISR.
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Appendix 1
A quarter of a three-layer artery model was created, with an 
inner diameter of 4 mm and a length of 60 mm. The arterial 
wall had a thickness of 0.75 mm, including the adventitia 
layer of 0.25 mm, the media layer of 0.375 mm and the 
intima layer of 0.125 mm. In the radial direction, the intima, 
media and adventitia layers were meshed with 1, 3 and 2 
rows of C3D8R elements, respectively. Three steps were set 
up for the simulation. In step 1, the artery was expanded by 
a uniform pressure applied on its inner surface increasing 
linearly from 0 to 0.04 MPa. In step 2, the deflation was 
modelled by releasing the pressure on the inner surface of 
the artery. In step 3, the tissue growth was simulated for all 
three vessel layers. The model parameters (both tissue dam-
age and growth models) for the three arterial layers were 
provided in Fereidoonnezhad et al. (2017). The evolution of 
the growth stretch obtained from this simulation is shown in 
Fig. 16 for the intima layer after angioplasty, which agrees 
with the results in Fereidoonnezhad et al. (2017). This veri-
fies our VUMAT subroutine programmed to model the tissue 
growth after PCI.
Appendix 2
In Fereidoonnezhad et al. (2017), the continuity equation is 
expressed as
In our study, it is proposed that
Substitution of Eqs. (17) and (12) into Eq. (16) leads to
By solving the above Eq. (18), the following can be 
obtained:
So, the growth stretch 휆g in our study followed the con-
tinuity equation.
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Fig. 16  Evolution of growth stretch in intima layer after angioplasty, 
in comparison with that in Fereidoonnezhad et al. (2017)
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